Immucell (ICCC) Return on Sales [ROS] (2010 - 2026)
Immucell (ICCC) reported Return on Sales [ROS] of 26.93% for Q2 2026, up 18.09 percentage points from 8.84% a year earlier.
Powered by 
Analysis
Immucell (ICCC) Return on Sales [ROS] (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Immucell's Return on Sales [ROS] came in at 9.22%, up 3.08 percentage points year-over-year; for FY2025, it was 5.97%, up 12.16 percentage points from FY2024.
- Return on Sales [ROS] has a five-year change of +14.96 percentage points (FY2020 to FY2025).
- By year, Return on Sales [ROS] came in at -6.19% in FY2024 (+26.71 pp), -32.90% in FY2023 (-20.52 pp), -12.38% in FY2022 (-13.72 pp) and 1.34% in FY2021 (+10.33 pp).
- The Q2 2026 figure ranks as the highest quarterly Return on Sales [ROS] in data going back to Q2 2010.
- Year over year, Return on Sales [ROS] gained in six of the last seven quarters, with an average year-over-year change of +18.59 percentage points.
- The high point for year-over-year Return on Sales [ROS] in five years was Q1 2024 (a gain of 61.32 percentage points); the low point was Q1 2023 (a drop of 74.97 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,144.36 Bn | 1,112.95 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 635.36 Bn | 555.22 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 502.79 Bn | 475.90 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.08 Bn | 310.46 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 300.87 Bn | 264.86 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 264.31 Bn | 237.99 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 239.07 Bn | 194.47 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 194.50 Bn | 168.70 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 171.00 Bn | 117.64 Bn | 10.94 Bn | 28.37% |
| 10 | Immucell | 94.00 Mn | 71.44 Mn | 2.44 Mn | 26.93% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 26.93% |
| Dec 31, 2025 | -0.76% |
| Sep 30, 2025 | 0.36% |
| Jun 30, 2025 | 8.84% |
| Mar 31, 2025 | 13.85% |
| Dec 31, 2024 | 8.02% |
| Sep 30, 2024 | -9.56% |
| Jun 30, 2024 | -25.34% |
| Mar 31, 2024 | -4.13% |
| Dec 31, 2023 | -38.34% |
| Sep 30, 2023 | -21.94% |
| Jun 30, 2023 | -36.93% |
| Mar 31, 2023 | -65.46% |
| Dec 31, 2022 | -41.77% |
| Sep 30, 2022 | -12.86% |
| Jun 30, 2022 | -16.03% |
| Mar 31, 2022 | 9.51% |
| Dec 31, 2021 | 2.67% |
| Sep 30, 2021 | 5.26% |
| Jun 30, 2021 | 4.74% |
API Access
Immucell Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ICCC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "ICCC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ICCC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();